Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cusatuzumab
cusatuzumab
OncoVerity eyes cusatuzumab development in AML after licensing rights
Pharmaceutical Technology
Tue, 03/28/23 - 10:41 pm
OncoVerity
Argenx
AML
cusatuzumab
Johnson & Johnson culls $1.6B argenx blood cancer drug collab
Fierce Biotech
Mon, 06/7/21 - 11:02 am
JNJ
biobucks
Belgium
Argenx
cusatuzumab
ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
Fierce Biotech
Mon, 12/3/18 - 09:55 am
Argenx
Cilag
Janssen
cusatuzumab
ASH2018
blood cancers